Lisanti Capital Growth, LLC Bluebird Bio, Inc. Transaction History

Lisanti Capital Growth, LLC

  • $344 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 15, 2018
SELL
$105.8 - $150.94 $329,038 - $469,423
-3,110 Closed
0 $0
Q4 2017

Feb 07, 2018
BUY
$81.25 - $130.7 $73,125 - $117,629
900 Added 40.72%
3,110 $554,000
Q3 2017

Nov 13, 2017
BUY
$57.74 - $91.42 $127,605 - $202,038
2,210
2,210 $304,000

Others Institutions Holding BLUE

# of Institutions
152
Shares Held
63.7M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $25.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Lisanti Capital Growth, LLC Portfolio

Follow Lisanti Capital Growth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email